The peptide remains available through "research peptide" suppliers who sell it labeled as "not for human consumption." This legal gray area allows it to be purchased without a prescription, compounding the safety concern: the purity, sterility, and actual contents of these products are not guaranteed by any regulatory body
Supports gut lining comfort and normal barrier function*2,4
Cardiovascular Support Antioxidant protection for heart and blood vessels
The mitochondria are like the batteries of the cell, they produce the energy needed for conducting cellular functions

Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations

Support addiction recovery by improving neurotransmitter balance